Artemis Medicare Services Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Artemis Consolidated Revenue from Operations up 13.8% in Q2 (YoY); EBITDA up 17.2%; Net Profit up 35.6%".
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services shared its Q2 financial performance through a press release dated November 11, 2025. Consolidated revenue from operations grew 13.8% year-on-year, showing steady top-line expansion. EBITDA rose 17.2% YoY, indicating improvement in operating profitability. Net profit surged 35.6% YoY, the strongest of the three metrics, suggesting better cost management and margin expansion. Overall, the healthcare company delivered broad-based growth across revenue, operating profit, and bottom line.
Net profit growing much faster than revenue points to improving margins and operational efficiency, which is a positive sign for shareholders and may support positive sentiment in the stock.